Both in Pharmaceuticals
Abeona Therapeutics vs Standard BioTools
Over the past year ABEO returned −9.0% and LAB returned −50.8%; their daily moves had a correlation of 0.25.
ABEO −9.0% LAB −50.8%Growth of $1, one year, split-adjusted
| Metric | ABEO | LAB |
|---|---|---|
| Price | $4.35 | $0.6100 |
| Market cap | $248.8M | $240.8M |
| Today | −4.61% | −1.61% |
| 1 month | −13.2% | −16.2% |
| 6 months | −19.9% | −34.8% |
| Year to date | −17.5% | −52.3% |
| 1 year | −12.8% | −48.7% |
| Revenue growth (YoY) | +2745.0% | −7.6% |
| Gross margin | 63.3% | 52.4% |
| Net margin | −177.4% | −133.1% |
| P/E (TTM) | — | 2.8× |
| Price / sales | 9.7× | 2.8× |
| Net cash | $131.8M | $476.4M |
| Dividend yield | — | — |
| Volatility (60d) | 54.5% | 45.5% |
| Short % of float | 36.2% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).